OTCMKTS:AMBBY Ambu A/S (AMBBY) Stock Forecast, Price & News $10.57 0.00 (0.00%) (As of 09/28/2023 ET) Add Compare Share Share Today's Range$10.57▼$10.5750-Day Range$10.57▼$15.5052-Week Range$8.40▼$16.85Volume31 shsAverage Volume870 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileProfileAnalyst RatingsChartCompetitorsHeadlinesShort InterestProfileAnalyst RatingsChartCompetitorsHeadlinesShort Interest About Ambu A/S (OTCMKTS:AMBBY) StockAmbu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers extrication collars, CPR breathing barriers, video laryngoscopes, and training manikins. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.Read More AMBBY Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AMBBY Stock News HeadlinesSeptember 29, 2023 | bbc.co.ukA 360° King's coronation view inside Westminster AbbeySeptember 29, 2023 | finance.yahoo.comAMBU FINANCIAL CALENDAR FOR 2023/24September 29, 2023 | PressReach (Ad)Uranium Prices Surge as Nuclear Energy Becomes KeyRenewed interest in uranium and rising prices have created a favorable environment for new projects.September 23, 2023 | americanbankingnews.comReviewing Biotricity (OTCMKTS:BTCY) & Ambu A/S (OTCMKTS:AMBBY)August 31, 2023 | finance.yahoo.comINTERIM REPORT FOR Q3 2022/23August 30, 2023 | markets.businessinsider.comAmbu A-S Bearer and-or registered B is about to announce earnings — here's what Wall Street expectsAugust 16, 2023 | forbes.comEarning A Master’s In Homeland Security: What To KnowJuly 28, 2023 | finance.yahoo.comGrant of Performance Share Units and reporting of transactions in accordance with Article 19 of the Market Abuse RegulationSeptember 29, 2023 | PressReach (Ad)Uranium Prices Surge as Nuclear Energy Becomes KeyRenewed interest in uranium and rising prices have created a favorable environment for new projects.July 25, 2023 | nbcnews.comIn one of the world's deadliest cities, a musician's idea pays offJuly 22, 2023 | health.usnews.comDr. Abbey S. HawkinsJuly 10, 2023 | finance.yahoo.comAMBU UPGRADES FULL-YEAR 2022/23 EARNINGS EXPECTATIONS ON THE BACK OF PRELIMINARY Q3 2022/23 RESULTSMay 19, 2023 | usatoday.comFelony charges, no trial: How a traffic stop upended her life for three yearsMay 3, 2023 | finance.yahoo.comINTERIM REPORT FOR Q2 2022/23 AND THE HALF-YEARMarch 28, 2023 | finance.yahoo.comREGISTRATION OF SHARE CAPITAL INCREASE OF 11,577,957 NEW B SHARES COMPLETEDMarch 23, 2023 | finance.yahoo.comCOMPLETION OF DIRECTED ISSUE OF 11,577,957 NEW B SHARES AND 250,000 EXISTING TREASURY B SHARESMarch 23, 2023 | finance.yahoo.comCORRECTION: AMBU A/S SEEKS TO STRENGTHEN ITS CAPITAL BASEMarch 21, 2023 | finance.yahoo.comAMBU PRESENTS UPDATED MARKET POTENTIAL ASSUMPTIONS AT ITS CAPITAL MARKETS DAY 2023, AND SPECIFIES LONG-TERM FINANCIAL TARGETSFebruary 7, 2023 | finance.yahoo.comINTERIM REPORT FOR Q1 2022/23February 7, 2023 | finance.yahoo.comAMBU CAPITAL MARKETS DAY 2023November 15, 2022 | finance.yahoo.comANNUAL RESULTS 2021/22 (EARNINGS RELEASE)November 15, 2022 | finance.yahoo.comAnnual Report 2021/22October 15, 2022 | yahoo.comAmbu, the World Leader in Single-Use Endoscopy, Hosts Grand Opening of New Manufacturing Plant in MexicoSeptember 7, 2022 | yahoo.comAmbu Donates Lifesaving Resuscitators to International Medical Corps as Part of the Ambu® BagTM’s 65th Birthday CelebrationAugust 28, 2022 | wsj.comAmbu A/S ADRAugust 27, 2022 | seekingalpha.comAmbu A/S (AMBFF) Q3 2022 Earnings Call TranscriptAugust 25, 2022 | finance.yahoo.comINTERIM REPORT FOR Q3 2021/22See More Headlines Receive AMBBY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Ambu A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:AMBBY CUSIPN/A CIKN/A Webwww.ambu.com Phone(457) 225-2000FaxN/AEmployees4,500Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 10 Best Stocks to Own in 2023Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio. Get This Free Report Key ExecutivesMs. Britt Meelby Jensen (Age 50)Chief Exec. Officer Comp: $620.62kMr. Thomas Frederik Schmidt (Age 52)Exec. VP & CFO Comp: $580.9kMr. Thomas Lykke Henriksen (Age 50)Head of HR Systems Comp: $10.32kHolger HesseFounderMr. Henrik AnkjærExec. VP of Global OperationsMr. Finn MohringChief Technology OfficerMr. Nicolai ThomsenDirector of Investor Relations & Strategic Financial PlanningMikkel Trier WagnerDirector of Corp. CommunicationsMr. Bassel RifaiExec. VP, Chief Marketing Officer & Pres APACMr. Måns BarsneExec. VP of Global Innovation & Chief Innovation OfficerMore ExecutivesKey CompetitorsBICO Group AB (publ)OTCMKTS:CLLKFCaliber Imaging & DiagnosticsOTCMKTS:LCDXCell MedXOTCMKTS:CMXCCellaVision AB (publ)OTCMKTS:CLVSFCochlearOTCMKTS:CHEOYView All Competitors AMBBY Stock - Frequently Asked Questions Should I buy or sell Ambu A/S stock right now? 3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ambu A/S in the last year. There are currently 1 sell rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" AMBBY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AMBBY, but not buy additional shares or sell existing shares. View AMBBY analyst ratings or view top-rated stocks. How have AMBBY shares performed in 2023? Ambu A/S's stock was trading at $12.94 at the beginning of 2023. Since then, AMBBY stock has decreased by 18.3% and is now trading at $10.57. View the best growth stocks for 2023 here. What is Ambu A/S's stock symbol? Ambu A/S trades on the OTCMKTS under the ticker symbol "AMBBY." How do I buy shares of Ambu A/S? Shares of AMBBY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Ambu A/S's stock price today? One share of AMBBY stock can currently be purchased for approximately $10.57. How many employees does Ambu A/S have? The company employs 4,500 workers across the globe. How can I contact Ambu A/S? Ambu A/S's mailing address is Baltorpbakken 13, Ballerup 2750, Denmark. The official website for the company is www.ambu.com. The company can be reached via phone at (457) 225-2000. This page (OTCMKTS:AMBBY) was last updated on 9/29/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ambu A/S Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.